Recent Patents on Anti-Cancer Drug Discovery,volume 2,issue 1  (01-2007)

Period of time： 2007年1期

Publisher： Bentham Science Publishers

Founded in： 2006

Total resources： 37

E-ISSN： 2212-3970|2|1

ISSN： 1574-8928

Subject： R73 Oncology

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Recent Patents on Anti-Cancer Drug Discovery,volume 2,issue 1

Menu

Author Index To Volume 1

Recent Patents on Anti-Cancer Drug Discovery,volume 2,issue 1 , Vol. 2, Iss. 1, 2007-01 , pp. i-ii

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Therapeutic Transfer of DNA Encoding Adenoviral E1A

Recent Patents on Anti-Cancer Drug Discovery,volume 2,issue 1 , Vol. 2, Iss. 1, 2007-01 , pp. 1-10

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Author Index To Volume 1

Recent Patents on Anti-Cancer Drug Discovery,volume 2,issue 1 , Vol. 2, Iss. 1, 2007-01 , pp. ii-ii

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Subject Index To Volume 1

Recent Patents on Anti-Cancer Drug Discovery,volume 2,issue 1 , Vol. 2, Iss. 1, 2007-01 , pp. iii-vi

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Subject Index To Volume 1

Recent Patents on Anti-Cancer Drug Discovery,volume 2,issue 1 , Vol. 2, Iss. 1, 2007-01 , pp. vi-vi

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Ribonucleotide Reductase: A Critical Enzyme for Cancer Chemotherapy and Antiviral Agents

Recent Patents on Anti-Cancer Drug Discovery,volume 2,issue 1 , Vol. 2, Iss. 1, 2007-01 , pp. 11-29

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Inhibitors of Steroidal Cytochrome P450 Enzymes as Targets for Drug Development

Recent Patents on Anti-Cancer Drug Discovery,volume 2,issue 1 , Vol. 2, Iss. 1, 2007-01 , pp. 31-58

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors as Anti-Angiogenic Agents in Cancer Therapy

Recent Patents on Anti-Cancer Drug Discovery,volume 2,issue 1 , Vol. 2, Iss. 1, 2007-01 , pp. 59-71

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

New Perspectives in the Treatment of Melanoma: Anti-Angiogenic and Anti-Lymphangiogenic Strategies

Recent Patents on Anti-Cancer Drug Discovery,volume 2,issue 1 , Vol. 2, Iss. 1, 2007-01 , pp. 73-78

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Small Molecule Vascular Disrupting Agents: Potential New Drugs for Cancer Treatment

Recent Patents on Anti-Cancer Drug Discovery,volume 2,issue 1 , Vol. 2, Iss. 1, 2007-01 , pp. 79-101

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 12 item(s)